trial

Shiatsu Adjuvant Therapy For Schizophrenia

NCTId NCT00425399
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 20 (estimated)
Sponsored by Herzog Hospital
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
20 (estimated)
Study type
Interventional
Allocation
Non Randomized
Model
Single Group
Masking
None
Start
2007-01
Primary completion
—
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
Shiatsu

Sponsors

Herzog HospitalLead Sponsor

Investigators

1
Pesach Lichtenberg, M.D.Principal Investigator

Sites

1 total
Jerusalem, Israel

Facts & assertions

3 sourced
Enrollment
20
Phase
NA
Status
COMPLETED
relationships
The graph out of here
drug
Shiatsu
drug
lead_sponsor
Herzog Hospital
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Pesach Lichtenberg, M.D.
person